From GlobeNewswire: 2025-06-06 16:07:00

Rakovina Therapeutics Inc. has closed a non-brokered private placement, raising $4,905,150 through the issuance of Units and Debenture Units. Each Unit includes a Common Share and a Warrant, while each Debenture Unit consists of a Debenture and Debenture Warrants. Insider subscriptions totaled $735,000. The Company plans to implement a 10-for-1 share consolidation post-private placement. Proceeds will support Rakovina’s growth, including AI-driven drug discovery tools integration. Fairfax Partners Inc. will handle Investor Relations, and Machai Capital Inc. will provide corporate communication services.

Rakovina Therapeutics Inc. successfully closed a private placement, raising $4,905,150 through Units and Debenture Units. Insider subscriptions totaled $735,000. The Company plans to implement a 10-for-1 share consolidation post-placement. Proceeds will support growth, including AI-driven drug discovery tools integration. Fairfax Partners Inc. will handle Investor Relations, and Machai Capital Inc. will provide corporate communication services.



Read more at GlobeNewswire: Rakovina Therapeutics Announces the Closing of